Skip to main content

Table 2 Comparison of upgraded or nonupgraded cases within different PIRADS score groups

From: The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy

  Upgrade Non-upgrade Total n(%) p value
ISUP1 + PIRADS5 43 (70.5%) 18 (29.5%) 61 (100%) 0.016
ISUP1 + PIRADS4 54 (62.7%) 32 (37%) 86 (100%) 0.062
ISUP1 + PIRADS3 12 (44%) 15 (55%) 27 (100%) 0.086